Tipranavir: a protease inhibitor for multi-drug resistant HIV-1

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.15, Iss.1, 2006-01, pp. : 59-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Interactions of Tipranavir, a New HIV Protease Inhibitor

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 81-84

Bentham Science Publishers

Access to resources Recommend Favorite

Tipranavir: A Novel Nonpeptidic Protease Inhibitor of HIV

By King Jennifer R. Acosta Edward P.

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 665-682

Adis International

Access to resources Recommend Favorite

Two Orthogonal Approaches to Overcome Multi-Drug Resistant HIV-1s: Development of Protease Inhibitors and Entry Inhibitors Based on CXCR4 Antagonists

Current Drug Targets - Infectious Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 103-110

Bentham Science Publishers

Access to resources Recommend Favorite

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

By de Mendoza Carmen Morelló Judit Garcia-Gascó Pilar Rodríguez-Novoa Sonia Soriano Vincent

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 839-850

Informa Healthcare

Access to resources Recommend Favorite

Tipranavir: a novel non-peptidic protease inhibitor for the treatment of HIV infection

By Mehandru Saurabh Markowitz Martin

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1821-1828

Informa Healthcare

Access to resources Recommend Favorite